Twitter icon
Facebook icon
YouTube icon
Instagram Icon

Congresswoman Ann McLane Kuster

Representing the 2nd District of New Hampshire

Combating the Opioid & Heroin Epidemic

The opioid and heroin epidemic is tearing communities apart in the Granite State and all across the country. This is a public health crisis, and we need to be doing everything we can to strengthen prevention, treatment, and recovery services and strategies. That’s why I co-founded the Bipartisan Heroin Task Force with my former colleague, Representative Frank Guinta (NH-01) in 2015. I have been proud to serve as co-chair of this task force since its inception, most recently with Representative Brian Fitzpatrick (PA-08).

The Task Force, which has more than 80 congressional members, aims to develop best practices and foster interagency collaboration to address the epidemic. In 2016, the Task Force successfully pushed for the passage of eighteen bills in one week which became part of the Comprehensive Addiction and Recovery Act (S.524). The Task Force has also held numerous hearings and briefings, both in Washington and in communities impacted by addiction, to educate lawmakers about effective means to curb the crisis.

In addition to founding the task force, I fought to include funding to address the opioid crisis in the 21st Century Cures Act (H.R. 6), and I introduced Carl’s Law (H.R. 5601), which would require any medication that contains an opiate to include a warning on its label identifying the presence of opioids and the possibility of drug-seeking behavior.

I am committed to continuing to work with my colleagues in Congress to bring an end to this deadly epidemic. 

More on Combating the Opioid & Heroin Epidemic

Jan 21, 2020 Press Release

Kuster, Murray and Warren send letter to Drug Enforcement Administration over delay in action to help people struggling with opioid addiction

Members call out two specific steps to expand treatment access that have gone unresolved despite being on DEA’s agenda for two years

DEA missed October deadline requiring it to increase access to medication-assisted treatment via telemedicine

DEA has yet to allow licensing of new mobile methadone clinics

Jan 17, 2020 Catching up with Annie

Dear Friend,

Combating the Opioid Epidemic with Commonsense Solutions

Jan 15, 2020 Press Release

Watch Rep. Kuster’s remarks here.

Jan 6, 2020 Event

Concord, NH – Today, Rep. Annie Kuster (NH-02) joined Granite State Progress for a discussion on H.R. 3, the Lower Drug Costs Now Act – historic legislation passed by the House in December that would lower the price of prescription drugs for all Americans by empowering Medicare to negotiate directly with drug companies.

Dec 20, 2019 Catching up with Annie

Dear Friend,

Giving Thanks and Sharing Holiday Cheer with our Veterans

Dec 18, 2019 Press Release

(Washington, DC) – U.S. Senator Jeanne Shaheen (D-NH), a senior member of the Senate Appropriations Committee, and U.S. Senator Maggie Hassan (D-NH) and Representatives Annie Kuster (NH-02) and Chris Pappas (NH-01) today announced the award of $750,000 in federal funding to the New Hampshire Department of Health and Human Services to improve quality of care and reduce costs for pregnant and postpartum women struggling with substance use and their infants. This funding is distributed from the U.S.

Dec 17, 2019 Press Release

Washington, DC – Today, Rep. Annie Kuster (NH-02), the founder and co-chair of the Bipartisan Opioid Task Force, voted in favor of legislation in the House of Representatives that would put forward over $5 billion in funding to combat the opioid epidemic. Kuster has long advocated for robust funding to tackle this serious public health crisis.

Dec 12, 2019 Press Release

Washington, D.C. – This week, Rep. Annie Kuster (NH-02) successfully secured the inclusion of $10 billion in funding toward the opioid epidemic over the next five years in H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, which the House will be voting on today.

Dec 12, 2019 Press Release

**H.R. 3 also include Kuster’s bill to ensure Medicare Beneficiaries are enrolled in a plan that best suits their needs**